• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cytokine Release Syndrome Resulting From Anti-Programmed Death-1 Antibody: Raising Awareness Among Community Oncologists.

作者信息

Adashek Michael L, Feldman Marvin

机构信息

Sinai Hospital, Baltimore, MD.

出版信息

J Oncol Pract. 2019 Sep;15(9):502-504. doi: 10.1200/JOP.19.00160. Epub 2019 Jul 16.

DOI:10.1200/JOP.19.00160
PMID:31310573
Abstract
摘要

相似文献

1
Cytokine Release Syndrome Resulting From Anti-Programmed Death-1 Antibody: Raising Awareness Among Community Oncologists.抗程序性死亡-1抗体引起的细胞因子释放综合征：提高社区肿瘤学家的认识
J Oncol Pract. 2019 Sep;15(9):502-504. doi: 10.1200/JOP.19.00160. Epub 2019 Jul 16.
2
Cytokine Release Syndrome with Pseudoprogression in a Patient with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab.帕博利珠单抗治疗晚期非小细胞肺癌患者时出现细胞因子释放综合征伴假性进展
J Thorac Oncol. 2019 Mar;14(3):e55-e57. doi: 10.1016/j.jtho.2018.11.025.
3
Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid.抗 PD-1 阻断后造血干细胞动员：移植后细胞因子释放综合征用抗坏血酸治疗。
Eur J Haematol. 2019 Aug;103(2):134-136. doi: 10.1111/ejh.13248. Epub 2019 Jun 7.
4
Pembrolizumab for classical Hodgkin's lymphoma.帕博利珠单抗用于经典型霍奇金淋巴瘤。
Lancet Oncol. 2016 Aug;17(8):e324. doi: 10.1016/S1470-2045(16)30301-1. Epub 2016 Jul 7.
5
Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy.接受抗程序性死亡受体-1治疗的非小细胞肺癌的胸部影像学表现
Curr Probl Diagn Radiol. 2019 Mar-Apr;48(2):142-147. doi: 10.1067/j.cpradiol.2018.01.005. Epub 2018 Jan 31.
6
Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.帕博利珠单抗 KEYNOTE-001：一项适应性研究，促成了两种适应症的加速批准及一种伴随诊断方法。
Ann Oncol. 2017 Jun 1;28(6):1388-1398. doi: 10.1093/annonc/mdx076.
7
Diabetic ketoacidosis following immunotherapy for lung cancer.肺癌免疫治疗后发生的糖尿病酮症酸中毒
Tidsskr Nor Laegeforen. 2019 Feb 25;139(4). doi: 10.4045/tidsskr.18.0597. Print 2019 Feb 26.
8
Antitumor and Anti-Hepatitis C Viral Response After Administration of the Anti-Programmed Death 1 Antibody Pembrolizumab.抗程序性死亡1抗体帕博利珠单抗给药后的抗肿瘤和抗丙型肝炎病毒反应
J Oncol Pract. 2017 Jul;13(7):462-464. doi: 10.1200/JOP.2016.019224. Epub 2017 May 31.
9
Anti-Ma2/Ta paraneoplastic rhombencephalitis in a patient with lung cancer responsive to anti-PD1 therapy.一名对抗PD1治疗有反应的肺癌患者发生的抗Ma2/Ta副肿瘤性菱形脑炎
Acta Neurol Belg. 2020 Apr;120(2):451-452. doi: 10.1007/s13760-019-01179-3. Epub 2019 Jul 1.
10
Making precision oncology the standard of care.使精准肿瘤学成为护理标准。
Lancet Oncol. 2017 Jul;18(7):835. doi: 10.1016/S1470-2045(17)30474-6.

引用本文的文献

1
Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study.新辅助派姆单抗治疗三阴性乳腺癌继发噬血细胞性淋巴组织细胞增生症/细胞因子释放综合征：病例报告
Front Oncol. 2024 Jun 11;14:1394543. doi: 10.3389/fonc.2024.1394543. eCollection 2024.
2
Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients - A case report and review of the literature.癌症患者中免疫检查点抑制剂诱导的严重细胞因子释放综合征——病例报告及文献综述
Heliyon. 2024 Jan 10;10(2):e24380. doi: 10.1016/j.heliyon.2024.e24380. eCollection 2024 Jan 30.
3
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
免疫检查点抑制剂的致命性系统性炎症综合征：病例报告和文献系统评价。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-005841.
4
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome.病例报告：一例甲氧苄啶/磺胺甲恶唑引发的低血压休克：与免疫检查点抑制剂及药物性超敏反应综合征相关的细胞因子释放综合征
Front Oncol. 2021 Apr 30;11:681997. doi: 10.3389/fonc.2021.681997. eCollection 2021.
5
Cytokine Release Syndrome Induced by Immune-checkpoint Inhibitor Therapy for Non-small-cell Lung Cancer.免疫检查点抑制剂治疗非小细胞肺癌引起的细胞因子释放综合征。
Intern Med. 2021 Nov 1;60(21):3459-3462. doi: 10.2169/internalmedicine.5922-20. Epub 2021 Mar 29.